Liposomal Systems as Nanocarriers for the Antiviral Agent Ivermectin
Romina Croci, Elisabetta Bottaro, Kitti Wing Ki Chan, Satoru Watanabe, Margherita Pezzullo, Eloise Mastrangelo, Claudio Nastruzzi
International Journal of Biomaterials, doi:10.1155/2016/8043983
RNA virus infections can lead to the onset of severe diseases such as fever with haemorrhage, multiorgan failure, and mortality. The emergence and reemergence of RNA viruses continue to pose a significant public health threat worldwide with particular attention to the increasing incidence of flaviviruses, among others Dengue, West Nile Virus, and Yellow Fever viruses. Development of new and potent antivirals is thus urgently needed. Ivermectin, an already known antihelminthic drug, has shown potent effects in vitro on Flavivirus helicase, with EC 50 values in the subnanomolar range for Yellow Fever and submicromolar EC 50 for Dengue Fever, Japanese encephalitis, and tick-borne encephalitis viruses. However ivermectin is hampered in its application by pharmacokinetic problems (little solubility and high cytotoxicity). To overcome such problems we engineered different compositions of liposomes as ivermectin carriers characterizing and testing them on several cell lines for cytotoxicity. The engineered liposomes were less cytotoxic than ivermectin alone and they showed a significant increase of the antiviral activity in all the Dengue stains tested (1, 2, and S221). In the current study ivermectin is confirmed to be an effective potential antiviral and liposomes, as drug carriers, are shown to modulate the drug activity. All together the results represent a promising starting point for future improvement of ivermectin as antiviral and its delivery.
Competing Interests The authors declare that there are no competing interests regarding the publication of this paper.
References
Alvinerie, Escudero, Sutra, Eeckhoutte, Galtier, The pharmacokinetics of moxidectin after oral and subcutaneous administration to sheep, Veterinary Research
Bassissi, Lespine, Alvinerie, Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration, Parasitology Research
Bollati, Alvarez, Assenberg, Structure and functionality in flavivirus NS-proteins: perspectives for drug design, Antiviral Research
Gonzalez Canga, Sahagun Prieto, Diez Liébana, Martínez, Vega et al., The pharmacokinetics and interactions of ivermectin in humans-a mini-review, AAPS Journal
Guzman, Kouri, Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987-2007, Transactions of the Royal Society of Tropical Medicine and Hygiene
Kuhn, Zhang, Rossmann, Structure of dengue virus: implications for flavivirus organization, maturation, and fusion, Cell
Lindenbach, Rice, Molecular biology of flaviviruses, Advances in Virus Research
Low, Ooi, Tolfvenstam, Early dengue infection and outcome study (EDEN)-study design and preliminary findings, Annals of the Academy of Medicine Singapore
Mastrangelo, Mazzitelli, Fabbri, Delivery of suramin as an antiviral agent through liposomal systems, ChemMedChem
Mastrangelo, Pezzullo, De Burghgraeve, Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug, Journal of Antimicrobial Chemotherapy
Rocha-Pereira, Jochmans, Debing, Verbeken, Nascimento et al., The viral polymerase inhibitor 2 -cmethylcytidine inhibits norwalk virus replication and protects against norovirus-induced diarrhea and mortality in a mouse model, Journal of Virology
Tay, Fraser, Chan, Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin, Antiviral Research
Vasilakis, Weaver, The history and evolution of human dengue emergence, Advances in Virus Research
Watanabe, Chan, Dow, Ooi, Low et al., Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: the search for a window for potential therapeutic efficacy, Antiviral Research
{ 'indexed': {'date-parts': [[2022, 4, 23]], 'date-time': '2022-04-23T16:25:36Z', 'timestamp': 1650731136751},
'reference-count': 14,
'publisher': 'Hindawi Limited',
'license': [ { 'start': { 'date-parts': [[2016, 1, 1]],
'date-time': '2016-01-01T00:00:00Z',
'timestamp': 1451606400000},
'content-version': 'unspecified',
'delay-in-days': 0,
'URL': 'http://creativecommons.org/licenses/by/4.0/'}],
'funder': [ { 'DOI': '10.13039/501100004963',
'name': 'Seventh Framework Programme',
'doi-asserted-by': 'publisher',
'award': ['260644', 'CRADA10262012']}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'published-print': {'date-parts': [[2016]]},
'abstract': '<jats:p>RNA virus infections can lead to the onset of severe diseases such as fever with '
'haemorrhage, multiorgan failure, and mortality. The emergence and reemergence of RNA viruses '
'continue to pose a significant public health threat worldwide with particular attention to '
'the increasing incidence of flaviviruses, among others Dengue, West Nile Virus, and Yellow '
'Fever viruses. Development of new and potent antivirals is thus urgently needed. Ivermectin, '
'an already known antihelminthic drug, has shown potent effects<jats:italic>in '
'vitro</jats:italic>on<jats:italic>Flavivirus</jats:italic>helicase, with '
'EC<jats:sub>50</jats:sub>values in the subnanomolar range for Yellow Fever and submicromolar '
'EC<jats:sub>50</jats:sub>for Dengue Fever, Japanese encephalitis, and tick-borne encephalitis '
'viruses. However ivermectin is hampered in its application by pharmacokinetic problems '
'(little solubility and high cytotoxicity). To overcome such problems we engineered different '
'compositions of liposomes as ivermectin carriers characterizing and testing them on several '
'cell lines for cytotoxicity. The engineered liposomes were less cytotoxic than ivermectin '
'alone and they showed a significant increase of the antiviral activity in all the Dengue '
'stains tested (1, 2, and S221). In the current study ivermectin is confirmed to be an '
'effective potential antiviral and liposomes, as drug carriers, are shown to modulate the drug '
'activity. All together the results represent a promising starting point for future '
'improvement of ivermectin as antiviral and its delivery.</jats:p>',
'DOI': '10.1155/2016/8043983',
'type': 'journal-article',
'created': {'date-parts': [[2016, 5, 8]], 'date-time': '2016-05-08T21:00:51Z', 'timestamp': 1462741251000},
'page': '1-15',
'source': 'Crossref',
'is-referenced-by-count': 26,
'title': 'Liposomal Systems as Nanocarriers for the Antiviral Agent Ivermectin',
'prefix': '10.1155',
'volume': '2016',
'author': [ { 'given': 'Romina',
'family': 'Croci',
'sequence': 'first',
'affiliation': [ { 'name': 'Department of Bioscience, University of Milan, 20133 Milan, '
'Italy'}]},
{ 'given': 'Elisabetta',
'family': 'Bottaro',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Life Sciences and Biotechnology, University of '
'Ferrara, 44121 Ferrara, Italy'}]},
{ 'given': 'Kitti Wing Ki',
'family': 'Chan',
'sequence': 'additional',
'affiliation': [ { 'name': 'Program in Emerging Infectious Diseases, Duke-NUS Graduate '
'Medical School, Singapore 169857'}]},
{ 'given': 'Satoru',
'family': 'Watanabe',
'sequence': 'additional',
'affiliation': [ { 'name': 'Program in Emerging Infectious Diseases, Duke-NUS Graduate '
'Medical School, Singapore 169857'}]},
{ 'given': 'Margherita',
'family': 'Pezzullo',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Bioscience, University of Milan, 20133 Milan, '
'Italy'}]},
{ 'given': 'Eloise',
'family': 'Mastrangelo',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Bioscience, University of Milan, 20133 Milan, '
'Italy'},
{ 'name': 'Institute of Biophysics, National Research Council, 20133 Milan, '
'Italy'}]},
{ 'given': 'Claudio',
'family': 'Nastruzzi',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Life Sciences and Biotechnology, University of '
'Ferrara, 44121 Ferrara, Italy'}]}],
'member': '98',
'reference': [ { 'key': '1',
'doi-asserted-by': 'crossref',
'first-page': '1',
'volume': '72',
'year': '2008',
'journal-title': 'Advances in Virus Research',
'DOI': '10.1016/S0065-3527(08)00401-6'},
{'key': '2', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.trstmh.2008.03.001'},
{'key': '3', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/s0092-8674(02)00660-8'},
{'key': '4', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S0065-3527(03)59002-9'},
{'key': '5', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.antiviral.2009.11.009'},
{'key': '6', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/jac/dks147'},
{ 'issue': '2',
'key': '9',
'first-page': '113',
'volume': '29',
'year': '1998',
'journal-title': 'Veterinary Research'},
{'key': '10', 'doi-asserted-by': 'publisher', 'DOI': '10.1208/s12248-007-9000-9'},
{'key': '11', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/cmdc.201300563'},
{ 'issue': '11',
'key': '12',
'first-page': '783',
'volume': '35',
'year': '2006',
'journal-title': 'Annals of the Academy of Medicine Singapore'},
{'key': '15', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.antiviral.2015.12.008'},
{'key': '16', 'doi-asserted-by': 'publisher', 'DOI': '10.1128/jvi.02064-13'},
{'key': '17', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s00436-005-0073-z'},
{'key': '18', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.antiviral.2013.06.002'}],
'container-title': 'International Journal of Biomaterials',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'http://downloads.hindawi.com/journals/ijbm/2016/8043983.pdf',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'http://downloads.hindawi.com/journals/ijbm/2016/8043983.xml',
'content-type': 'application/xml',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'http://downloads.hindawi.com/journals/ijbm/2016/8043983.pdf',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2017, 6, 24]],
'date-time': '2017-06-24T13:08:15Z',
'timestamp': 1498309695000},
'score': 1,
'resource': {'primary': {'URL': 'http://www.hindawi.com/journals/ijbm/2016/8043983/'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2016]]},
'references-count': 14,
'alternative-id': ['8043983', '8043983'],
'URL': 'http://dx.doi.org/10.1155/2016/8043983',
'relation': {},
'ISSN': ['1687-8787', '1687-8795'],
'subject': ['Biomedical Engineering', 'Biomaterials'],
'container-title-short': 'International Journal of Biomaterials',
'published': {'date-parts': [[2016]]}}
